International Clinical Trial: Application Value of Oral Perfluorobutane Microsphere Contrast-Enhanced Ultrasound in the Diagnosis of Gastroesophageal Reflux Disease

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133503) titled 'Application Value of Oral Perfluorobutane Microsphere Contrast-Enhanced Ultrasound in the Diagnosis of Gastroesophageal Reflux Disease' on Sept. 28.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Air Force Medical University

Condition: Gastroesophageal Reflux Disease

Intervention: Oral perfluorobutane microsphere group: 2ml,, 45µg/ml Sonazoid .+PEG(0.5:1000 mL)

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-10-27

Target Sample Size: Oral perfluorobutane microsphere group:50;Oral gastrointestinal filling ultraso...